GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro

Creative Commons License

Bildik G., Akin N., Senbabaoglu F., Sahin G. N., Karahuseyinoglu S., Ince Ü., ...Daha Fazla

HUMAN REPRODUCTION, cilt.30, sa.12, ss.2912-2925, 2015 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 12
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1093/humrep/dev257
  • Dergi Adı: HUMAN REPRODUCTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2912-2925
  • Anahtar Kelimeler: chemotherapy, ovarian failure, GnRH agonist, apoptosis, follicle reserve, granulosa cells, steroidogenic activity, BREAST-CANCER CHEMOTHERAPY, FERTILITY PRESERVATION, PREMENOPAUSAL WOMEN, ADJUVANT TREATMENT, HORMONE AGONISTS, GROWTH, CYCLOPHOSPHAMIDE, TRIPTORELIN, PACLITAXEL, DOCETAXEL
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

STUDY QUESTION: Is there any in vitro evidence for or against ovarian protection by co-administration of a GnRH agonist with chemotherapy in human?